$ONVO I love their business:
Organovo is an early-stage medical laboratory and research company which designs and develops functional, three dimensional human tissue (also known as 3D bioprinting technology) for medical research and therapeutic applications.
3D printing of organs? Who can't see how this is HUGE? Really. They have a product out there, they have sales, of course limited because they are dealing with distribution, regulation, and perfecting the tech. A bog part of their business now is to sell to research facilities so that companies can do experiment with these 3D printed organs.
But the stock is not doing too well, it's a stock that I want to love, but there's no love there from Wall Street.
Anyone can make a strong case pro or con this one?
Submitted March 16, 2017 at 08:38AM by PM_ME_BOOBPIX http://ift.tt/2mSthzy
